ketamine

SAGE-547: A Novel Treatment for Severe Postpartum Depression?

SAGE-547 (SAGE Therapeutics) is a new drug, an allosteric modulator of GABAA receptors, which is currently under investigation for the treatment of refractory seizure disorders.  It turns out that SAGE-547 may also be useful for [...]

By |2016-07-12T15:32:07-04:00July 7th, 2015|Medication, Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on SAGE-547: A Novel Treatment for Severe Postpartum Depression?
Go to Top